A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Twenty‐five patients with hand tremor of 2 + (moderate) to 4 + (severe) on the tremor severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (Allergan, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If patients failed to respond to the initial injection, they were eligible to receive another injection of 100 U 4 weeks later. Rest, postural, and kinetic tremors were evaluated at 2‐ to 4‐week intervals over a 16‐week study period using tremor severity rating scales, accelerometry, and assessments of improvement and disability. A signigicant improvment (p < 0.05) was observed on the tremor severity rating scale 4 weeks after injection in patients treated with BTX as compared with placebo, and this effect was maintained for the duration of the study. Four weeks after injection, 75% of BTX‐treated patients vs. 27% of placebo‐treated patients (p < 0.05). reported mild to moderate improvement (peak effect rating ≥2). There were no significant improvements in functional rating scales, although trends were observed for some items. Postural accelerometry measurements showed a ≥30% reduction in amplitude in nine of 12 BTX‐treated subjects and in one of nine placebo‐treated subjects (p < 0. 05). Although all patients treated with BTX reported some degree of finger weakness, no severe, irreversible, or unexpected adverse events occurred. Chemodenervation with BTX may significantly ameliorate essential hand tremor in patients who fail to improve with conventional pharmacologic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach has been used successfully with the advantage of providing very targeted relief (46–51).”
From Could Wearable and Mobile Technology Improve the Management of Essential Tremor? (2018) · cites this paper as [47]
Citations
Cites
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
Therapeutic Uses of Botulinum Toxin
Oates, J. A., Wood, A. J. J., Jankovic, J., & Brin, M. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241707 · Cited by 801
Self-citationParkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
Landis, J. R., Heyman, E. R., & Koch, G. G. (1978) · International Statistical Review / Revue Internationale de Statistique · doi:10.2307/1402373 · Cited by 454
A study of hereditary essential tremor
Bain, P. G., Findley, L. J., Thompson, P. D., Gresty, M. A., Rothwell, J. C., Harding, A. E., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.805 · Cited by 392
Tonic vibration reflex and muscle afferent block in writer's cramp
Kaji, R., Rothwell, J. C., Katayama, M., Ikeda, T., Kubori, T., Kohara, N., Mezaki, T., Shibasaki, H., & Kimura, J. (1995) · Annals of Neurology · doi:10.1002/ana.410380206 · Cited by 300
Is dystonia a sensory disorder?
Hallett, M. (1995) · Annals of Neurology · doi:10.1002/ana.410380203 · Cited by 297
Rivner, M. H. (1995) · Neurology · doi:10.1212/wnl.45.6.1244-a · Cited by 280
Anatomic guide for the electromyographer--the limbs
Delagi, E. F., & Perotto, A. (1980) · Thomas eBooks · Cited by 260
Lees, A. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.345-d · Cited by 255
Research works printed but not linked: 2
- Lou JS, 1991, Current neurology, 199
- Ludlow CL, 1989, Treatment of voice tremor with botulinum toxin injection [Abstract], Neurology, 39, 353
Cited by
Items 201–234 of 234
Tremor: Phenomenology, Etiology, Diagnosis, and Treatment
Dalvi, A., Pahwa, R., & Lyons, K. E. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_29
Botulinum Toxin Treatment in Multiple Sclerosis
Safarpour, Y., & Jabbari, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-56038-0_7
Unmet Needs and Challenges in the Therapeutic Use of Botulinum Neurotoxins
Simpson, D. M., & So, Y. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4928-9.00029-9
Jabbari, B. (2019) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2019-s1-001
“With the recent publication of one class I study on ET with positive results [9], and the two previous class II studies [7, 8], there is now established efficacy for BoNT-A therapy in ET.”
BackgroundMethodResultInfluentialFahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00013-5 · Cited by 2
Self-citationFahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50017-6
Self-citationTherapie essenzieller Tremorsyndrome
Becktepe, J. S., & Gövert, F. (2020) · NeuroTransmitter · doi:10.1007/s15016-020-7471-4
Evidence-Based Review of Current Botulinum Toxin Treatment Indications in Medicine
Vijayakumar, D., & Jankovic, J. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-50691-9_4 · Cited by 1
Self-citationCoughlin, D. G., & Deik, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-63583-7.00084-9
Pilleri, M., & Fumadó, J. C. (2003) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(03)70944-5
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00010-x
Self-citationJankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00012-3
Self-citation(2010) · Drugs & Therapy Perspectives · doi:10.2165/11205170-000000000-00000
Charles, D. P., & Gill, C. E. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841848525.027
Botulinum toxins in the treatment of dystonia
Stacy, M. A., & Hickey, P. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841848525.026
van der Lip, W. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1386-0_71
Dash, D., & Mestre, T. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197529652.003.0019
Botulinum Neurotoxins as a Therapeutic
Mehanna, R., & Jankovic, J. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_169
Self-citationEssential tremor in geriatric patients
Kim, M. S., Pyo, S. Y., & Seo, I. C. (2023) · Journal of Korean Society of Geriatric Neurosurgery · doi:10.51638/jksgn.2023.00038
“The improvement of the lateralized outcomes is 84% and for the tremor total score around [14].”
BackgroundInfluentialAsadi, B., Hassani, S., Ghanaati, H., Rahmatian, A., Azami, M., & Gheshlaghi, S. A. (2023) · Neurology Letters · doi:10.61186/nl.2.2.69
Treatment of Involuntary Movements (Dystonia, Tremor, Tic)
Jabbari, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-54471-2_8
A Toxin that Remedies a Large Number of Medical Problems: How It Happened?
Jabbari, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-54471-2_1
Einsatzmöglichkeiten des Botulinum- Neurotoxins bei der Parkinson-Krankheit
Jost, W. H., & Berberovic, E. (2024) · Nervenheilkunde · doi:10.1055/a-2241-9220
Prasad, S., & Pal, P. K. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.043
Botulinum Neurotoxin Treatment Outcomes for Upper Limb Tremors: A Literature Review
Sankar, K., Subairdeen, M. A., Muthukrishnan, N. K., Samhan, A. A. A., & Giri, J. P. (2025) · Studies in systems, decision and control · doi:10.1007/978-3-031-89771-9_94
Deep brain stimulation in movement disorders
Samancı, B. (2026) · Deep Brain Stimulation · doi:10.1016/j.jdbs.2026.02.003 · Cited by 1
Deep brain stimulation in movement disorders
Samancı, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-99742-3.00009-6
Ondo, W. G. (2026) · Seminars in Neurology · doi:10.1055/a-2832-4561
Evidenzbasierte Tremortherapie und Perspektiven der Behandlung
Gattermeyer‐Kell, L., & Schwingenschuh, P. (2026) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-026-4656-9
Mittal, S. O., & Jost, W. H. (2026) · Toxins · doi:10.3390/toxins18070280
“Fixed-dose injection of forearm flexors and extensors at predetermined doses, the approach used in the first two ET RCTs, produced dose-dependent tremor scale improvement but hand weakness in 30% of patients at low doses and 70% at high doses, with no consistent functional benefit [18,19].”
Wang, G., Cheng, L., & Liao, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1886329
“Jankovic (1996) permitted rescue dosing after Week 4; only the randomized comparison before rescue dosing was used (30).”
InfluentialNon-surgical treatment of essential tremor: What's in store?
AlMojel, M., & Fasano, A. A. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108967
Simpson, D. M., Banach, M., Aldred, J., Lee, J., Ondo, W., Pagán, F., Bagretsova, A., Klein, G., Geister, T. L., Pulte, I., et al. (2026) · Toxins · doi:10.3390/toxins18100435
“Initial double-blind, placebo-controlled studies used fixed doses of onabotulinumtoxinA and reported efficacy over placebo in patients with ET of the hand [8,9].”
Tratamiento del temblor con toxina botulínica
Cristóbal, G. L. (2010) · Elsevier eBooks · doi:10.1016/b978-84-458-2022-3.50012-9
Metadata
- Authors
- Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jankovic, J.
- ORCID
- Jankovic, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1996-05
- Volume
- 11
- Issue
- 3
- Pages
- 250-256
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2010076187
- Cited by
- 235
- References
- 15
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 8 · 2012: 10
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- botulinum toxin type A, wrist flexors, wrist extensors, accelerometry, postural tremor, kinetic tremor, chemodenervation
- MeSH terms
- Aged, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Electromyography, Female, Hand, Humans, Injections, Intramuscular, Male, Middle Aged, Motor Skills, Neurologic Examination, Signal Processing, Computer-Assisted, Tremor, Treatment Outcome, Botulinum Toxins, Type A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.